🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aoshuang Chang

Guiyang Medical University

ORCID: 0000-0002-1986-2909

Also affiliated with Affiliated Hospital of Guizhou Medical University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 1 paper. Top paper: “Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation”.

Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation

Evidence-Based Complementary and Alternative Medicine(2022)10.1155/2022/2383527
N/A
0.457DataRank · unranked
20 citations

Yuhong Wang, Lihai Ma, Aoshuang Chang, Lingzhan Meng, Liang Zhang +1 more